October 19, 2015

CryoPod™ Takes Top Award at ESBB

Industry-First Portable Cryogenic Biospecimen Carrier with Data Logging Capability Receives Second Award for Innovation

ESBB AwardSAN RAFAEL, Calif., Oct. 20, 2015 -–BioCision, LLC today announced that their jointly-developed CryoPod™ Carrier liquid nitrogen (LN2)-based portable carrying system received the first ever European Society for Biopreservation and Biobanking (ESBB) Innovation Award at the recent 2015 ESBB annual meeting held in London, England.  The award recognizes the best new innovative product or technology that improves the workflow related to biospecimen storage and handling.

“The CryoPod Carrier was chosen for its ability to improve the workflow, with an easy-to-integrate elegant design,’ said Erik Steinfelder, President of ESBB. “The capabilities of the CryoPod Carrier span from the complex to the practical, including highly professional and easy to understand documentation. It was our clear choice for this first-of-its-kind award.”

“CryoPod Carrier has won two innovation awards at both the 2015 International Society for Biological and Environmental Repositories (ISBER) meeting in May and now at ESBB,” said, Rolf O. Ehrhardt, MD, PhD, BioCision Chief Executive Officer. “This recognition, coupled with the strong demand for this product from customers, demonstrates the necessity for a new generation of cryogenic sample handling products.”

The CryoPod Carrier is a liquid nitrogen vapor-based hand-portable solution that addresses a previously unmet need in cryogenic sample transport and handling. It provides safe, reliable and portable cryogenic transport for biospecimens at -150°C or lower temperature for more than 4 hours on a single LN2 charge. The instrument displays temperature, date and time, as well as user settable audible and visual alarms. It also features logging functionality, enabling operators to record and download the temperature and event history as needed. The carrier can be manually filled or works seamlessly with its automated filling station that replenishes the LN2 charge in less than 15 minutes. 

About BioCision, LLC

BioCision is a life science research and development company that provides tools to standardize critical processes throughout the healthcare industry. BioCision’s award-winning portfolio of translational products can be integrated throughout research, development and manufacturing workflows, enabling consistent temperature control for sensitive therapeutics and biological samples. By addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.

For more information visit www.biocision.com, or visit the BioCision blog for news and expert insight at blog.biocision.com.

Media contact information:

Marla Kertzman


CoolCell® Controlled-rate cell freezing equivalent to CRFs

Contact BioCision:

About Us
Contact Us
Privacy Policy

© Copyright 2018, BioCision.
All rights reserved

BioCision is a life science research and development company that develops products and solutions for process standardization throughout the healthcare industry through the application of advanced thermal regulation principles and technologies. The intuitive design and interconnectivity of BioCision products enables researchers, clinicians and manufacturers to protect the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. By comprehensively addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.

Help 1-800-367-4887